Reduced maternal serum concentrations of angiopoietin-2 in the first trimester precede intrauterine growth restriction associated with placental insufficiency

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 114, Issue 11, 2007, Pages 1427-1431

  Wang, Y ^a,b   Tasevski, V ^c   Wallace, E M ^d   Gallery, E D ^a,b   Morris, J M ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Angiopoietin 2; Intrauterine growth restriction

Indexed keywords

ANGIOPOIETIN 2; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; HUMAN; INTRAUTERINE GROWTH RETARDATION; MATERNAL SERUM; NEWBORN; NORMAL HUMAN; PLACENTA INSUFFICIENCY; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

EID: 35348932127     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2007.01511.x     Document Type: Article

References (6)

1. Harman CR, Baschat AA. Arterial and venous Dopplers in IUGR. Clin Obstet Gynecol 2003 46 : 931 46.
2. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997 277 : 55 60.
3. Hirokoshi K, Maeshima Y, Kobayashi K, Matsuura E, Sugiyama H, Yamasaki Y, et al. Increase of serum angiopoietin-2 during pregnancy is suppressed in women with preeclampsia. Am J Hypertens 2005 18 : 1181 8.
4. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci U S A 1999 96 : 3149 53.
5. Geva E, Ginzinger DG, Zaloudek CJ, Moore DH, Byrne A, Jaffe RB. Human placental vascular development: vasculogenic and angiogenic (branching and non-branching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. J Clin Endocrinol Metab 2002 87 : 4213 24.
6. Thirkill T, Douglas G. The vitronectin receptor plays a role in the adhesion of human cytotrophoblast cells to endothelial cells. Endothelium 1999 6 : 277 90.